// App-Quantinova.ai

P1252 : PREDICTING THE RESPONSE OF DLBCL CELLS TO BH3-MIMETICS USING SYSTEMS BIOLOGY

Researchers

Presenter

  • Ielyaas Cloete

Principal Investigators

  • Victoria Smith

  • Ross Jackson

  • Andrea Pepper

  • Chris Pepper

  • Martin Dyer

  • Simon Mitchell

Medical Centers

  • Brighton and Sussex Medical School,Brighton,Vereinigtes Königreich

  • Brighton &amp

  • The Ernest and Helen Scott Haematological Research Institute,Leceister,Royaume-uni

  • The Ernest and Helen Scott Haematological Research Institute,Leceister,Royaume-uni

  • The Ernest and Helen Scott Haematological Research Institute,Leceister,Royaume-uni

  • Sussex Medical School,Brighton,Reino Unido

  • The Ernest and Helen Scott Haematological Research Ins

  • Brighton and Sussex Medical School,Brighton,Vereinigtes Königreich

  • The Ernest and Helen Scott Haematological Research Institute,Leceister,Royaume-uni

  • Bright

  • Sussex Medical School,Brighton,Reino Unido

  • Sussex Medical School,Brighton,United Kingdom

  • Brighton and Sussex Medical School,Brighton,Royaume-uni

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • B-cell lymphoma-extra large

  • B-cell lymphoma 2

  • Myeloid Cell Leukemia 1

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved